Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice
Human Gene Therapy Clinical Development | September 7, 2016 | Volume: 27 | Issue: 4 | Pages: 145-151
10.1089/humc.2016.062